Standard
Companion and Complementary Diagnostics-Focus on PD-L1 Expression Assays for PD-1/PD-L1 Checkpoint Inhibitors in Non-Small Cell Lung Cancer. / Hersom, Maria; Jorgensen, Jan T.
In:
Therapeutic Drug Monitoring, Vol. 40, No. 1, 02.2018, p. 9-16.
Research output: Contribution to journal › Review › Research › peer-review
Harvard
Hersom, M & Jorgensen, JT 2018, '
Companion and Complementary Diagnostics-Focus on PD-L1 Expression Assays for PD-1/PD-L1 Checkpoint Inhibitors in Non-Small Cell Lung Cancer',
Therapeutic Drug Monitoring, vol. 40, no. 1, pp. 9-16.
https://doi.org/10.1097/FTD.0000000000000460APA
Hersom, M., & Jorgensen, J. T. (2018).
Companion and Complementary Diagnostics-Focus on PD-L1 Expression Assays for PD-1/PD-L1 Checkpoint Inhibitors in Non-Small Cell Lung Cancer.
Therapeutic Drug Monitoring,
40(1), 9-16.
https://doi.org/10.1097/FTD.0000000000000460Vancouver
Hersom M, Jorgensen JT.
Companion and Complementary Diagnostics-Focus on PD-L1 Expression Assays for PD-1/PD-L1 Checkpoint Inhibitors in Non-Small Cell Lung Cancer.
Therapeutic Drug Monitoring. 2018 Feb;40(1):9-16.
https://doi.org/10.1097/FTD.0000000000000460Author
Hersom, Maria ; Jorgensen, Jan T. / Companion and Complementary Diagnostics-Focus on PD-L1 Expression Assays for PD-1/PD-L1 Checkpoint Inhibitors in Non-Small Cell Lung Cancer. In: Therapeutic Drug Monitoring. 2018 ; Vol. 40, No. 1. pp. 9-16.
Bibtex
@article{4caec12f42e3421f90021fedf3f6c922,
title = "Companion and Complementary Diagnostics-Focus on PD-L1 Expression Assays for PD-1/PD-L1 Checkpoint Inhibitors in Non-Small Cell Lung Cancer",
keywords = "companion diagnostics, complementary diagnostics, drug-diagnostic codevelopment, PD-L1, immune checkpoint inhibitors, NSCLC, precision medicine",
author = "Maria Hersom and Jorgensen, {Jan T.}",
year = "2018",
month = feb,
doi = "10.1097/FTD.0000000000000460",
language = "English",
volume = "40",
pages = "9--16",
journal = "Therapeutic Drug Monitoring",
issn = "0163-4356",
publisher = "Lippincott Williams & Wilkins",
number = "1",
}
RIS
TY - JOUR
T1 - Companion and Complementary Diagnostics-Focus on PD-L1 Expression Assays for PD-1/PD-L1 Checkpoint Inhibitors in Non-Small Cell Lung Cancer
AU - Hersom, Maria
AU - Jorgensen, Jan T.
PY - 2018/2
Y1 - 2018/2
KW - companion diagnostics
KW - complementary diagnostics
KW - drug-diagnostic codevelopment
KW - PD-L1
KW - immune checkpoint inhibitors
KW - NSCLC
KW - precision medicine
U2 - 10.1097/FTD.0000000000000460
DO - 10.1097/FTD.0000000000000460
M3 - Review
C2 - 29084031
VL - 40
SP - 9
EP - 16
JO - Therapeutic Drug Monitoring
JF - Therapeutic Drug Monitoring
SN - 0163-4356
IS - 1
ER -
